Enzymatic activity profile of a Brazilian culture collection of Candida albicans isolated from diabetics and non-diabetics with oral candidiasis

Mycoses

Volumn 57, Issue 6, 2014, Pages 351-357

  Sanitá, Paula Volpato ^a   Zago, Chaiene Evelin ^a   Pavarina, Ana Cláudia ^a   Jorge, Janaina Habib ^a   Machado, Ana Lúcia ^a   Vergani, Carlos Eduardo ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Candida albicans; Diabetes mellitus; Oral candidiasis; Phospholipase; Secreted aspartyl proteinase

Indexed keywords

AGAR; ASPARTIC PROTEINASE; PHOSPHOLIPASE; CULTURE MEDIUM; VIRULENCE FACTOR;

ARTICLE; BRAZIL; CANDIDA ALBICANS; CELL SUSPENSION; DIABETES MELLITUS; DIABETIC PATIENT; ENZYME ACTIVITY; ENZYME RELEASE; FUNGAL VIRULENCE; FUNGUS CULTURE; FUNGUS ISOLATION; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THRUSH; CHEMISTRY; CULTURE MEDIUM; ENZYMOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ASPARTIC ACID PROTEASES; BRAZIL; CANDIDA ALBICANS; CANDIDIASIS, ORAL; CULTURE MEDIA; DIABETES COMPLICATIONS; HUMANS; MICROBIOLOGICAL TECHNIQUES; PHOSPHOLIPASES; VIRULENCE FACTORS;

EID: 84900424527     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12162     Document Type: Article

References (44)

1. Mima EG, Vergani CE, Machado AL et al. Comparison of photodynamic therapy versus conventional antifungal therapy for the treatment of denture stomatitis: a randomized clinical trial. Clin Microbiol Infect 2012; 18: E380-8.
2. Sanitá PV, Machado AL, Pavarina AC, Massucato EM, Colombo AL, Vergani CE. Microwave denture disinfection versus nystatin in treating patients with well-controlled type 2 diabetes and denture stomatitis: a randomized clinical trial. Int J Prosthodont 2012; 25: 232-44.
3. Silva MM, Mima EG, Colombo AL et al. Comparison of denture microwave disinfection and conventional antifungal therapy in the treatment of denture stomatitis: a randomized clinical study. Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 114: 469-79.
4. Negrato CA, Tarzia O. Buccal alterations in diabetes mellitus. Diabetol Metab Syndr 2010; 2: 3.
5. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315-21.
6. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999; 26: 259-65.
7. Darwazeh AMG, Lamey PJ, Samaranayake LP et al. The relationship between colonisation, secretor status and in vitro adhesion of Candida albicans to buccal epithelial cells from diabetics. J Med Microbiol 1990; 33: 43-49.
8. Dorocka-Bobkowska B, Budtz-Jorgensen E, Wloch S. Non-insulin-dependent diabetes mellitus as a risk factor for denture stomatitis. J Oral Pathol Med 1996; 25: 411-5.
9. Belazi M, Velegraki A, Fleva A et al. Candidal overgrowth in diabetic patients: potential predisposing factors. Mycoses 2005; 48: 192-6.
10. Dorocka-Bobkowska B, Zozulinska-Ziolkiewicz D, Wierusz-Wysocka B, Hedzelek W, Szumala-Kakol A, Budtz-Jörgensen E. Candida-associated denture stomatitis in type 2 diabetes mellitus. Diabetes Res Clin Pract 2010; 90: 81-86.
11. Motta-Silva AC, Aleva NA, Chavasco JK, Armond MC, França JP, Pereira LJ. Erythematous oral candidiasis in patients with controlled type II diabetes mellitus and complete dentures. Mycopathologia 2010; 169: 215-23.
12. Sanitá PV, Pavarina AC, Giampaolo ET et al. Candida spp. prevalence in well controlled type 2 diabetic patients with denture stomatitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011; 111: 726-33.
13. Calderone RA, Fonzi WA. Virulence factors of Candida albicans. Trends Microbiol 2001; 9: 327-35.
14. Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol 2003; 11: 30-36.
15. Samaranayake LP, Raeside JM, MacFarlane TW. Factors affecting the phospholipase activity of Candida species in vitro. Sabouraudia 1984; 22: 201-7.
16. Banno Y, Yamada T, Nozawa Y. Secreted phospholipases of dimorphic fungus, Candida albicans; separation to three enzymes and some biological properties. Sabouraudia 1985; 23: 47-54.
17. Hube B. Candida albicans secreted aspartyl proteases. Curr Top Med Mycol 1996; 1: 55-69.
18. Kantarcioglu AS, Yücel A. Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains. Mycoses 2002; 45: 160-5.
19. Koga-Ito CY, Lyon JP, Vidotto V, de Resende MA. Virulence factors and antifungal susceptibility of Candida albicans isolates from oral candidosis patients and control individuals. Mycopathologia 2006; 161: 219-23.
20. Lyon JP, Resende MA. Correlation between adhesion, enzyme production, and susceptibility to fluconazole in Candida albicans obtained from denture wearers. Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 632-8.
21. Manfredi M, McCullough MJ, Al-Karaawi ZM, Vescovi P, Porter S. In vitro evaluation of virulence attributes of Candida spp. isolated from patients affected by diabetes mellitus. Oral Microbiol Immunol 2006; 21: 183-9.
22. Tsang CS, Chu FC, Leung WK, Jin LJ, Samaranayake LP, Siu SC. Phospholipase, proteinase and haemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus. J Med Microbiol 2007; 56(Pt 10): 1393-8.
23. Pinto E, Ribeiro IC, Ferreira NJ, Fortes CE, Fonseca PA, Figueiral MH. Correlation between enzyme production, germ tube formation and susceptibility to fluconazole in Candida species isolated from patients with denture-related stomatitis and control individuals. J Oral Pathol Med 2008; 37: 587-92.
24. Thiele MC, Carvalho AP, Gursky LC, Rosa RT, Samaranayake LP, Rosa EA. The role of candidal histolytic enzymes on denture-induced stomatitis in patients living in retirement homes. Gerodontology 2008; 25: 229-36.
25. Negri M, Martins M, Henriques M, Svidzinski TI, Azeredo J, Oliveira R. Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients. Mycopathologia 2010; 169: 175-82.
26. Rajendran R, Robertson DP, Hodge PJ, Lappin DF, Ramage G. Hydrolytic enzyme production is associated with Candida albicans biofilm formation from patients with type 1 diabetes. Mycopathologia 2010; 170: 229-35.
27. D'Eça Júnior A, Silva AF, Rosa FC, Monteiro SG, de Maria Silva Figueiredo P, de Andrade Monteiro C. In vitro differential activity of phospholipases and acid proteinases of clinical isolates of Candida. Rev Soc Bras Med Trop 2001; 44: 334-8.
28. Ramage G, Coco B, Sherry L, Bagg J, Lappin DF. In vitro Candida albicans biofilm induced proteinase activity and SAP8 expression correlates with in vivo denture stomatitis severity. Mycopathologia 2012; 174: 11-19.
29. Newton AV. Denture sore mouth. A possible etiology. Br Dent J 1962; 112: 357-60.
30. Alves SH, Milan EP, de Laet-Sant'Ana P, Oliveira LO, Santurio JM, Colombo AL. Hypertonic Sabouraud broth as a simple and powerful test for Candida dubliniensis screening. Diagn Microbiol Infect Dis 2002; 43: 85-86.
31. Price MF, Wilkinson ID, Gentry LO. Plate methods for detection of phospholipase activity in Candida albicans. Sabouraudia 1982; 20: 7-14.
32. Rüchel R. Proteinases of pathogenic fungi. Mycoses 1999; 42: 48-52.
33. Marcos-Arias C, Eraso E, Madariaga L, Aguirre JM, Quindós G. Phospholipase and proteinase activities of Candida isolates from denture wearers. Mycoses 2011; 54: e10-6.
34. Sudbery P, Gow N, Berman J. The distinct morphogenic states of Candida albicans. Trends Microbiol 2004; 12: 317-24.
35. Ganendren R, Widmer F, Singhal V, Wilson C, Sorrell T, Wright L. In vitro antifungal activities of inhibitors of phospholipases from the fungal pathogen Cryptococcus neoformans. Antimicrob Agents Chemother 2004; 48: 1561-9.
36. Gauwerky K, Borelli C, Korting HC. Targeting virulence: a new paradigm for antifungals. Drug Discov Today 2009; 14: 214-22.
37. Naglik JR, Newport G, White TC et al. In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis. Infect Immun 1999; 67: 2482-90.
38. Rüchel R. A variety of Candida proteinases and their possible targets of proteolytic attack in the host. Zentralbl Bakteriol Mikrobiol Hyg A 1984; 257: 266-74.
39. Colina AR, Aumont F, Deslauriers N, Belhumeur P, de Repentigny L. Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase. Infect Immun 1996; 64: 4514-9.
40. Cassone A, de Bernardis F, Mondello F, Ceddia T, Agatensi L. Evidence for a correlation between proteinase secretion and vulvovaginal candidosis. J Infect Dis 1987; 156: 777-83.
41. Närhi T, Ainamo A, Meurman J. Salivary yeasts, saliva and oral mucosa in the elderly. J Dent Res 1993; 72: 1009-14.
42. Lerman U, Morschhauser J. Secreted aspartic proteases are not required for invasion of reconstituted human epithelia by Candida albicans. Microbiology 2008; 154: 3281-95.
43. Silva S, Henriques M, Oliveira R et al. Characterization of Candida parapsilosis infection of an in vitro reconstituted human oral epithelium. Eur J Oral Sci 2009; 117: 669-75.
44. Silva S, Hooper SJ, Henriques M, Oliveira R, Azeredo J, Williams DW. The role of secreted aspartyl proteinases in Candida tropicalis invasion and damage of oral mucosa. Clin Microbiol Infect 2011; 17: 264-72.